Barclays’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.33M | Sell |
|
|||||
|
2025
Q2 | $12M | Buy |
|
|||||
|
2025
Q1 | $9.32M | Sell |
|
|||||
|
2024
Q4 | $8.68M | Buy |
|
|||||
|
2024
Q3 | $8.53M | Buy |
|
|||||
|
2024
Q2 | $511K | Sell |
|
|||||
|
2024
Q1 | $1.03M | Sell |
|
|||||
|
2023
Q4 | $1.39M | Buy |
|
|||||
|
2023
Q3 | $541K | Buy |
|
|||||
|
2023
Q2 | $411K | Buy |
|
|||||
|
2023
Q1 | $283K | Buy |
|
|||||
|
2022
Q4 | $264K | Buy |
|
|||||
|
2022
Q3 | $140K | Sell |
|
|||||
|
2022
Q2 | $218K | Sell |
|
|||||
|
2022
Q1 | $331K | Sell |
|
|||||
|
2021
Q4 | $736K | Buy |
|
|||||
|
2021
Q3 | $255K | Buy |
|
|||||
|
2021
Q2 | $185K | Sell |
|
|||||
|
2021
Q1 | $601K | Buy |
|
|||||
|
2020
Q4 | $447K | Sell |
|
|||||
|
2020
Q3 | $462K | Buy |
|
|||||
|
2020
Q2 | $433K | Buy |
|
|||||
|
2020
Q1 | $509K | Sell |
|
|||||
|
2019
Q4 | $852K | Buy |
|
|||||
|
2019
Q3 | $669K | Sell |
|
|||||
|
2019
Q2 | $1.02M | Sell |
|
|||||
|
2019
Q1 | $1.69M | Sell |
|
|||||
|
2018
Q4 | $1.09M | Buy |
|
|||||
|
2018
Q3 | $868K | Buy |
|
|||||
|
2018
Q2 | $665K | Sell |
|
|||||
|
2018
Q1 | $655K | Buy |
|
|||||
|
2017
Q4 | $681K | Buy |
|
|||||
|
2017
Q3 | $361K | Buy |
|
|||||
|
2017
Q2 | $176K | Sell |
|
|||||
|
2017
Q1 | $277K | Sell |
|
|||||
|
2016
Q4 | $562K | Buy |
|
|||||
|
2016
Q3 | $221K | Sell |
|
|||||
|
2016
Q2 | $1.19M | Buy |
|
|||||
|
2016
Q1 | $378K | Sell |
|
|||||
|
2015
Q4 | $1.17M | Buy |
|
|||||
|
2015
Q3 | $639K | Buy |
|
|||||
|
2015
Q2 | $813K | Sell |
|
|||||
|
2015
Q1 | $1.28M | Buy |
|
|||||
|
2014
Q4 | $52K | Sell |
|
|||||
|
2014
Q3 | $115K | Buy |
|
|||||
|
2014
Q2 | $18K | Sell |
|
|||||
|
2014
Q1 | $43K | Buy |
|
|||||
|
2013
Q4 | $13K | Sell |
|
|||||
|
2013
Q3 | $6K | Sell |
|
|||||
|
2013
Q2 | $5K | Buy |
|